Tetrahydrobiopterin is the rate-limiting factor in catecholamine synthesis. Defective tetrahydrobiopterin metabolism may cause reduced neurotransmitter production and hence disease of the central nervous system.' In children suffering from malignant hyperphenylalaninaemia, a specific deficiency of intracellular tetrahydrobiopterin has been shown to be the direct cause of their degenerative brain disease. ' In malignant hyperphenylalaninaemia due to reduced tetrahydrobiopterin synthesis serum biopterin concentration is lowered 1-' and in malignant hyperphenylalaninaemia caused by dihydropteridine reductase deficiency, serum biopterin levels are elevated. ' I We now report serum biopterin levels in a group of patients with senile dementia of Alzheimer type.
Methods and subjects

Patients
The patients were from the acute psychiatric assessment unit at All Saints Hospital, Birmingham. There were 7 males and 11 females, with a mean age of 79 ± 6-8 years (mean ± SD). The In Group 2 were patients free of any mental symptoms They were nine males and 11 females with a mean age of 75 + 6-0 years (mean ± SD). Nine of these patients were not on any drugs and the rest were on one or more of the following drugs: digoxine, dipyridamole, a phenothiazine, chlormethiazole, frusemide, sulphinpyrazone, lorzepam and cimetidine. The healthy hospital staff and university staff and students were volunteers in a survey to establish biopterin levels in different body fluids of normal population. None *of these subjects were on any drugs. They were 231 volunteers. The results of the survey have already been published.5 In this study we have only used results from 13 subjects, whose ages ranged from 51 to 66 years. Our reason for this selection was that they were the nearest age group to the Senile dementia of Alzheimer type patients.
They were five males and eight females. These subjects [10 When comparing Senile Dementia of Alzheimer Type patients to the schizophrenics, it is clear that the serum biopterin mean concentration for the Senile Dementia of Alzheimer Type former patients as a whole group was lower than the mean value in the schizophrenic patients (1-51 ± 0-07 ,.g/l; p < 0-01)( Table 4 ). The male Senile Dementia of Alzheimer Type patients had serum biopterin levels lower than those of the male schizophrenic patients (1-60 ± 0.08 ,ug/l; p < 0.05). The female Senile Dementia of Alzheimer Type patients also had their mean serum biopterin concentrations (1.18 ± 0.09) lower than those of female schizophrenics (1-30 ± 0-06 ,g/l) though-the difference did not reach statistical significance.
The results from the chlorpromazine trial (table  5) showed that a single dose of 50 mg of chlorpromazine did not change the serum biopterin concentration. 
